IL-17 levels are increased in tumor tissues and in the sera of colon cancer patients [12,13], and a high expression of IL-17 in tumor regions has been proposed as an indicator of prognosis in patients with colorectal carcinoma [14]. This evidence concerns the gene IL17A and neoplasm.